Clinical Trial Detail

NCT ID NCT02549989
Title Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

endometrial carcinoma

Therapies

LY3023414

Age Groups: senior adult

Additional content available in CKB BOOST